HealthEquity Reports Record Q4 Sales, Strong FY26 Account Growth, Reaffirms Guidance

summarizeSummary

HealthEquity reported record Q4 sales and strong fiscal year 2026 growth in HSAs and total accounts, with HSA assets increasing by 14%. The company reaffirmed its fiscal 2026 and 2027 guidance, expecting to be at the high end of its FY26 projections.

check_boxKey Events

• Record Sales and Account Growth

  HealthEquity delivered a standout fiscal 2026 sales year, adding over one million new HSA accounts, with Q4 new HSAs from sales rising 17% year-over-year. Total HSAs reached 10.6 million (up 7%) and Total Accounts hit 17.8 million (up 4%).

• Significant HSA Asset Expansion

  Total HSA Assets grew to $36.5 billion as of January 31, 2026, marking a 14% increase from the prior year. HSA investments specifically increased by 26% year-over-year to $18.5 billion.

• Guidance Reaffirmed

  The company reaffirmed its previously provided outlook for fiscal years 2026 and 2027, expecting fiscal 2026 results to be near the top end of its guidance ranges. Updated full guidance for fiscal 2027 will be provided in March.

• HSA Cash Repricing Schedule Provided

  An updated HSA cash repricing schedule was disclosed, showing $17.3 billion in total HSA cash with an average annualized yield of 3.6% as of January 31, 2026.

auto_awesomeAnalysis

HealthEquity, Inc. announced robust preliminary operational metrics for fiscal year 2026, highlighted by record fourth-quarter sales and significant growth in HSA accounts and assets. The company's ability to add over one million new HSA accounts and grow HSA assets by 14% year-over-year demonstrates strong execution in a competitive market. Reaffirming guidance and expecting to be at the top end of previously provided ranges signals confidence in its financial performance. This positive operational update, especially while the stock is trading near its 52-week low, could provide a boost to investor sentiment and suggests a solid foundation for future growth.